Trailing-twelve-month (TTM) revenue is $3.05 Billion with a year-over-year growth of +82.86%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $725,106,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $721,628,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $782,615,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $817,925,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,047,274,000 |
Current P/S: $6,958,530,599 market capitalization ÷ $3,047,274,000 TTM revenue = 2.28x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $817.92M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:16.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Reportable Segment | $1.4B | $2.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $1M | $3M | $4M | $5M | $6M | $13M |
| Europe | $34M | $38M | $31M | $44M |
$3.05B
$3.05 Billion
+82.86%
vs. $1.67B a year ago (TTM)
+74.65%
5 Year compound annual growth rate
1 Year
+82.86%
3 Year
+47.36%
5 Year
+74.65%
10 Year
+67.29%
15 Year
+47.43%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.52B | +$1.16B | +85.54% |
| 2024 | $1.36B | +$37.62M | +2.85% |
| 2023 | $1.32B | +$664.41M | +101.65% |
| 2022 | $653.60M | +$339.33M | +107.97% |
| 2021 | $314.27M | +$183.55M | +140.41% |
| 2020 |
TTM Growth
+82.86%
3-Year CAGR
+47.36%
5-Year CAGR
+74.65%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:16.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $73M |
| North America | $95M | $273M | $617M | $1.3B | $1.3B | $2.4B |
|---|
| Other | $425,323 | $631,649 | $1M | $6M | $7M | $7M |
|---|
| $130.73M |
| +$55.58M |
| +73.96% |
| 2019 | $75.15M | +$22.54M | +42.85% |
| 2018 | $52.60M | +$16.44M | +45.46% |
| 2017 | $36.16M | +$13.40M | +58.89% |
| 2016 | $22.76M | +$5.54M | +32.19% |
